Taiki Kamijima

6PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical virologyRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 15, 2026
Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis.

|May 02, 2026
Fibroblast-mediated KRAS activation in double-negative prostate cancer.

|Apr 07, 2026
Urethral Closure Mechanism Caused by Prostate Rotation During Abdominal Pressure in Men: A Dynamic Magnetic Resonance Imaging Study.

Hiroshi Kano, Yoshifumi Kadono, Ryunosuke Nakagawa

|Feb 27, 2026
High-Dose-Rate Brachytherapy Combined with External Beam Radiotherapy for Newly Defined Very High-Risk and Regional Prostate Cancer: A 17-Year Single-Institution Experience.

Tomoyuki Makino, Takayuki Sakurai, Shigeyuki Takamatsu

|Dec 30, 2025
Dynamic Changes in Albumin and Systemic Immune-Inflammation Index as Prognostic Markers in Patients Treated with Cabozantinib After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.

Rikushi Fujimura, Hiroshi Yaegashi, Ryunosuke Nakagawa

|Oct 16, 2025
Seven-Year PSA ≤ 0.2 ng/mL After High-Dose-Rate Brachytherapy Indicates Eligibility for Discontinuing PSA Surveillance in Prostate Cancer.

Tomoyuki Makino, Takayuki Sakurai, Shigeyuki Takamatsu

Pageof 1

Frequent Collaborators

6 joint publications

Ryunosuke Nakagawa

6 joint publications

Hiroaki Iwamoto

6 joint publications

Atsushi Mizokami

5 joint publications

Tomoyuki Makino